1. Home
  2. PMN vs SURG Comparison

PMN vs SURG Comparison

Compare PMN & SURG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMN
  • SURG
  • Stock Information
  • Founded
  • PMN 2004
  • SURG 2006
  • Country
  • PMN Canada
  • SURG United States
  • Employees
  • PMN N/A
  • SURG N/A
  • Industry
  • PMN Pharmaceuticals and Biotechnology
  • SURG Advertising
  • Sector
  • PMN Health Care
  • SURG Consumer Discretionary
  • Exchange
  • PMN Nasdaq
  • SURG Nasdaq
  • Market Cap
  • PMN 23.9M
  • SURG 27.0M
  • IPO Year
  • PMN N/A
  • SURG N/A
  • Fundamental
  • Price
  • PMN $0.75
  • SURG $2.25
  • Analyst Decision
  • PMN Strong Buy
  • SURG Strong Buy
  • Analyst Count
  • PMN 1
  • SURG 1
  • Target Price
  • PMN $6.00
  • SURG $8.50
  • AVG Volume (30 Days)
  • PMN 26.2K
  • SURG 4.5M
  • Earning Date
  • PMN 05-13-2025
  • SURG 03-25-2025
  • Dividend Yield
  • PMN N/A
  • SURG N/A
  • EPS Growth
  • PMN N/A
  • SURG N/A
  • EPS
  • PMN 0.11
  • SURG N/A
  • Revenue
  • PMN N/A
  • SURG $60,881,173.00
  • Revenue This Year
  • PMN N/A
  • SURG $59.22
  • Revenue Next Year
  • PMN N/A
  • SURG $75.86
  • P/E Ratio
  • PMN $6.87
  • SURG N/A
  • Revenue Growth
  • PMN N/A
  • SURG N/A
  • 52 Week Low
  • PMN $0.62
  • SURG $1.05
  • 52 Week High
  • PMN $2.61
  • SURG $4.38
  • Technical
  • Relative Strength Index (RSI)
  • PMN 42.22
  • SURG 63.22
  • Support Level
  • PMN $0.63
  • SURG $1.70
  • Resistance Level
  • PMN $0.76
  • SURG $2.50
  • Average True Range (ATR)
  • PMN 0.05
  • SURG 0.25
  • MACD
  • PMN 0.00
  • SURG 0.09
  • Stochastic Oscillator
  • PMN 40.94
  • SURG 50.81

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; Lead Generation is a generation and case management solutions company serving law firms in the mass tort industry; and Others. It generates the revenue from Mobile Virtual Network Operator segment.

Share on Social Networks: